Wed, April 27, 2022

Vikram Purohit Maintained (AXSM) at Hold with Decreased Target to $27 on, Apr 27th, 2022

Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Decreased Target from $34 to $27 on, Apr 27th, 2022.

Vikram has made no other calls on AXSM in the last 4 months.



There are 2 other peers that have a rating on AXSM. Out of the 2 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram


  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Increased Target to $77 on, Tuesday, March 29th, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 2nd, 2022